IT1402149B1 - Uso di un fosfopeptide in grado di bloccare l interazione her3/p85 per il trattamento dei tumori iperesprimenti her2. - Google Patents

Uso di un fosfopeptide in grado di bloccare l interazione her3/p85 per il trattamento dei tumori iperesprimenti her2.

Info

Publication number
IT1402149B1
IT1402149B1 ITRM2010A000517A ITRM20100517A IT1402149B1 IT 1402149 B1 IT1402149 B1 IT 1402149B1 IT RM2010A000517 A ITRM2010A000517 A IT RM2010A000517A IT RM20100517 A ITRM20100517 A IT RM20100517A IT 1402149 B1 IT1402149 B1 IT 1402149B1
Authority
IT
Italy
Prior art keywords
phosphopeptide
her3
interaction
treatment
block
Prior art date
Application number
ITRM2010A000517A
Other languages
English (en)
Inventor
Giulia Bon
Rita Falcioni
Valentina Folgiero
Carlo Selene Eleonora Di
Original Assignee
Ist Fisioterap Ospitalroma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ist Fisioterap Ospitalroma filed Critical Ist Fisioterap Ospitalroma
Priority to ITRM2010A000517A priority Critical patent/IT1402149B1/it
Priority to US13/877,450 priority patent/US20130259929A1/en
Priority to PCT/IT2011/000336 priority patent/WO2012046260A1/en
Priority to EP11782682.6A priority patent/EP2624858A1/en
Publication of ITRM20100517A1 publication Critical patent/ITRM20100517A1/it
Application granted granted Critical
Publication of IT1402149B1 publication Critical patent/IT1402149B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1808—Epidermal growth factor [EGF] urogastrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
ITRM2010A000517A 2010-10-04 2010-10-04 Uso di un fosfopeptide in grado di bloccare l interazione her3/p85 per il trattamento dei tumori iperesprimenti her2. IT1402149B1 (it)

Priority Applications (4)

Application Number Priority Date Filing Date Title
ITRM2010A000517A IT1402149B1 (it) 2010-10-04 2010-10-04 Uso di un fosfopeptide in grado di bloccare l interazione her3/p85 per il trattamento dei tumori iperesprimenti her2.
US13/877,450 US20130259929A1 (en) 2010-10-04 2011-09-29 Use of a phosphopeptide able to block her3/p85 interaction for the treatment of her2 hyper-expressing tumours
PCT/IT2011/000336 WO2012046260A1 (en) 2010-10-04 2011-09-29 Use of a phosphopeptide able to block her3/p85 interaction for the treatment of her2 hyper-expressing tumours
EP11782682.6A EP2624858A1 (en) 2010-10-04 2011-09-29 Use of a phosphopeptide able to block her3/p85 interaction for the treatment of her2 hyper-expressing tumours

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM2010A000517A IT1402149B1 (it) 2010-10-04 2010-10-04 Uso di un fosfopeptide in grado di bloccare l interazione her3/p85 per il trattamento dei tumori iperesprimenti her2.

Publications (2)

Publication Number Publication Date
ITRM20100517A1 ITRM20100517A1 (it) 2012-04-05
IT1402149B1 true IT1402149B1 (it) 2013-08-28

Family

ID=43738282

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM2010A000517A IT1402149B1 (it) 2010-10-04 2010-10-04 Uso di un fosfopeptide in grado di bloccare l interazione her3/p85 per il trattamento dei tumori iperesprimenti her2.

Country Status (4)

Country Link
US (1) US20130259929A1 (it)
EP (1) EP2624858A1 (it)
IT (1) IT1402149B1 (it)
WO (1) WO2012046260A1 (it)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2480099C (en) * 2002-03-26 2019-01-08 Zensun (Shanghai) Sci-Tech. Ltd. Erbb3 based methods and compositions for treating neoplasms
AR056857A1 (es) * 2005-12-30 2007-10-24 U3 Pharma Ag Anticuerpos dirigidos hacia her-3 (receptor del factor de crecimiento epidérmico humano-3) y sus usos
AU2010284018C1 (en) * 2009-08-21 2015-10-15 Merrimack Pharmaceuticals, Inc. Antibodies against the ectodomain of ErbB3 and uses thereof

Also Published As

Publication number Publication date
US20130259929A1 (en) 2013-10-03
ITRM20100517A1 (it) 2012-04-05
EP2624858A1 (en) 2013-08-14
WO2012046260A1 (en) 2012-04-12

Similar Documents

Publication Publication Date Title
HUS1900007I1 (hu) Kiméra, antigénreceptor-módosított T-sejt alkalmazása rák kezelésére
IL235261B (en) Antibodies against claudin 18.2 useful in cancer diagnosis
LT3333161T (lt) 2-(2,4,5-pakeistieji-anilino)pirimidino dariniai kaip egfr moduliatoriai, naudingi vėžio gydymui
ME02397B (me) Pirazolo[1,5-a]pirimidini i -triazini kao antiviralni agensi
HUE049886T2 (hu) Tumorspecifikus neoantigéneket tartalmazó készítmények, tumorok kezelésében történõ alkalmazásra
DK2580243T3 (da) Antibodies against human cd38
EA201401204A1 (ru) Антитела к il-23p19
HUE061909T2 (hu) Pirazolo[1,5-a]pirimidinek alkalmazása ATR kináz inhibítorként, rákos megbetegedések kezelésére
IL226326A0 (en) Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof
PT2536730E (pt) Compostos pirrolopirimidina enquanto inibidores de cdk4/6
DK2658435T3 (da) Integreret dobbelt swept kilde til medicinsk oct afbildning
EP2647009A4 (en) ANALOG MEMORY WITH FERROELECTRIC CAPACITORS
LT2658871T (lt) Antikūnai prieš cd38
ZA201407544B (en) Pharmaceutical composition comprising olmesartan medoxomil and rosuvastatin or its salt
DK2513107T3 (da) Heteroaromatiske phenylimidazol-derivater som pde10a-enzyminhibitorer
FR2955770B1 (fr) Composition cosmetique.
HRP20180670T1 (hr) Novi postupak dobivanja spojeva namijenjenih upotrebi u liječenju raka
SMT201400156B (it) Composizione di gel di brimonidina
SG11201507575QA (en) Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics
EP2695897A4 (en) NEW ANTI-RECEPTOR ANTIBODY OF IL-23 HUMAN
PL2420222T3 (pl) Aksamitny w dotyku lakier do paznokci
FR2964566B1 (fr) Composition cosmetique pour le maquillage des levres
DK3003363T3 (da) Immunogen sammensætning til anvendelse i terapi
FR2955018B1 (fr) Applicateur cosmetique.
SMT201700061B (it) Vaccino dna di her2 come trattamento aggiuntivo per tumori in animali di compagnia